GERMEEN SIDAROUS: Open Payments
NPI 1063125524 · FORT WASHINGTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$688 in 33 payments from 13 companies in 2025. Trend: 2023 $610 · 2024 $1,574 · 2025 $688
Food & beverage: $688
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 8 | $148 |
| LEO Pharma Inc. | 4 | $95 |
| Galderma Laboratories, L.P. | 2 | $63 |
| ABBVIE INC. | 3 | $62 |
| GENZYME CORPORATION | 2 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $56 |
| Janssen Biotech, Inc. | 2 | $55 |
| STRATA Skin Sciences, Inc. | 5 | $47 |
| Amgen Inc. | 1 | $32 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $25 |
Products named: Bimzelx, ADBRY, NEMLUVIO, SKYRIZI, DUPIXENT, TREMFYA, XTRAC, Otezla.
Industry payments across MD — which companies pay providers there.
